Cascadian Therapeutics, Inc. – Plans of Reorganization, Merger, Acquisition or Similar – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 92 pages Agreement and Plan of Merger

from SC TO-C 96 pages Agreement and Plan of Merger Among Seattle Genetics, Inc. (“Parent”), Valley Acquisition Sub, Inc. (“Merger Sub”) and Cascadian Therapeutics, Inc. (The “Company”) Dated as of January 30, 2018

from 8-K 48 pages Agreement and Plan of Reorganization by and Among Oncothyreon Inc. Ab Acquisition (De) Corp., Alpine Biosciences, Inc. and Mitchell H. Gold, M.D., as Stockholders’ Agent August 8, 2014 Exhibits

from 10-K 3 pages Amendment No. 1 to Agreement and Plan of Reorganization

from S-4/A 56 pages Agreement and Plan of Reorganization by and Among Biomira Inc., Prolx Pharmaceuticals Corporation, D. Lynn Kirkpatrick and Garth Powis and With Respect to Articles VI and VII Only, Garth Powis as Stockholder Representative Dated as of October 30, 2006

from S-4 55 pages Agreement and Plan of Reorganization by and Among Biomira Inc., Prolx Pharmaceuticals Corporation, D. Lynn Kirkpatrick and Garth Powis and With Respect to Articles VI and VII Only, Garth Powis as Stockholder Representative Dated as of October 30, 2006